Chargement en cours...

Targeting Poly I:C to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFNα/β

Poly I:C is an adjuvant used for anti-tumor treatment and vaccines because of its prominent effects on CD8 T cells and NK cells. Poly I:C binds TLR3 and this interaction is thought to be central for driving cell-mediated immune responses. We investigated the importance of TLR3 in poly I:C-mediated e...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ngoi, Soo M., Tovey, Michael G., Vella, Anthony T.
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2676428/
https://ncbi.nlm.nih.gov/pubmed/19017955
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!